| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.4161/BBUG.1.1.9818 |
| P8608 | Fatcat ID | release_z5vgyewtjzhpfegzigiwz64x3i |
| P932 | PMC publication ID | 3035150 |
| P698 | PubMed publication ID | 21327123 |
| P5875 | ResearchGate publication ID | 49841746 |
| P50 | author | Jim O'Mahony | Q102065421 |
| Olivia McAuliffe | Q57011125 | ||
| Reynolds Paul Ross | Q62566537 | ||
| P2093 | author name string | Mark Fenton | |
| Aidan Coffey | |||
| P2860 | cites work | Prokaryotes: the unseen majority | Q22066200 |
| Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium | Q24563225 | ||
| Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme | Q24609957 | ||
| Bacteriophage lysis: mechanism and regulation | Q24634690 | ||
| Bacteriophage lysins as effective antibacterials | Q24648457 | ||
| Phage Lytic Enzyme Cpl-1 as a Novel Antimicrobial for Pneumococcal Bacteremia | Q24671527 | ||
| Crystal structures of a T4-lysozyme duplication-extension mutant demonstrate that the highly conserved beta-sheet region has low intrinsic folding propensity | Q27638222 | ||
| Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1 | Q27642277 | ||
| The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis | Q27643380 | ||
| The structure of bacteriophage T7 lysozyme, a zinc amidase and an inhibitor of T7 RNA polymerase | Q27731300 | ||
| Staphylococcus aureus infections | Q28131787 | ||
| Holins: the protein clocks of bacteriophage infections | Q28140369 | ||
| Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity | Q28144392 | ||
| C-terminal domains of Listeria monocytogenes bacteriophage murein hydrolases determine specific recognition and high-affinity binding to bacterial cell wall carbohydrates | Q28215660 | ||
| Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacteriophages | Q28278525 | ||
| AN INVESTIGATION ON THE NATURE OF ULTRA-MICROSCOPIC VIRUSES. | Q29039000 | ||
| Anthrax as a biological weapon, 2002: updated recommendations for management | Q29615587 | ||
| The crystal structure of the bacteriophage PSA endolysin reveals a unique fold responsible for specific recognition of Listeria cell walls | Q30159623 | ||
| The two-component cell lysis genes holWMY and lysWMY of the Staphylococcus warneri M phage varphiWMY: cloning, sequencing, expression, and mutational analysis in Escherichia coli | Q30160261 | ||
| Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae | Q33279810 | ||
| Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme | Q33555987 | ||
| A novel gene required for rhamnose-glucose polysaccharide synthesis in Streptococcus mutans | Q33638582 | ||
| Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes | Q33851733 | ||
| Gene cloning and expression and secretion of Listeria monocytogenes bacteriophage-lytic enzymes in Lactococcus lactis | Q33987196 | ||
| The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus | Q34077249 | ||
| Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. | Q43192489 | ||
| Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. | Q43511826 | ||
| Food-grade controlled lysis of Lactococcus lactis for accelerated cheese ripening | Q43682283 | ||
| Mechanism Of Phage-Induced Lysis In Pneumococci | Q43767971 | ||
| Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase | Q43820230 | ||
| Virus deals anthrax a killer blow | Q44111935 | ||
| The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. | Q44980874 | ||
| Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. | Q45172053 | ||
| Purified recombinant phage lysin LySMP: an extensive spectrum of lytic activity for swine streptococci | Q46097663 | ||
| Lytic activity of the recombinant staphylococcal bacteriophage PhiH5 endolysin active against Staphylococcus aureus in milk | Q46353015 | ||
| The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. | Q46415786 | ||
| In vitro antimicrobial susceptibility of Streptococcus suis strains isolated from clinically healthy sows in China | Q46579198 | ||
| Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis | Q46602101 | ||
| Structure and lytic activity of a Bacillus anthracis prophage endolysin | Q46639780 | ||
| PlyC, a novel bacteriophage lysin for compartment-dependent proteomics of group A streptococci | Q46839723 | ||
| Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. | Q46936223 | ||
| The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144. | Q50597508 | ||
| Mutational and biochemical analyses of the endolysin Lys(gaY) encoded by the Lactobacillus gasseri JCM 1131T phage phi gaY. | Q50895420 | ||
| Construction of a multifunctional pneumococcal murein hydrolase by module assembly | Q56903510 | ||
| Role for bacteriophages in the preparedness for fighting against pneumonia in the postantibiotic era | Q57113028 | ||
| Complications associated with Streptococcus equi infection on a horse farm | Q69472219 | ||
| Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling | Q71150328 | ||
| Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme | Q72738407 | ||
| Community-acquired pneumonia | Q77464123 | ||
| The non-enzymatic microbicidal activity of lysozymes | Q77780831 | ||
| Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin | Q79281958 | ||
| Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci | Q79448668 | ||
| Functional analysis of the lysis genes of Staphylococcus aureus phage P68 in Escherichia coli | Q80341250 | ||
| Bi-functional activities of chimeric lysozymes constructed by domain swapping between bacteriophage T7 and K11 lysozymes | Q80721130 | ||
| In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains | Q81162319 | ||
| Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats | Q34123647 | ||
| A bacteriolytic agent that detects and kills Bacillus anthracis | Q34145707 | ||
| The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains | Q34166006 | ||
| Holins: form and function in bacteriophage lysis | Q34304886 | ||
| The crisis in antibiotic resistance | Q34314442 | ||
| Bovine mastitis and intramammary drug delivery: review and perspectives | Q34334018 | ||
| Filamentous phage assembly: variation on a protein export theme | Q34432716 | ||
| Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases | Q34463971 | ||
| The two-component lysis system of Staphylococcus aureus bacteriophage Twort: a large TTG-start holin and an associated amidase endolysin | Q34471853 | ||
| Isolation and expression of the lysis genes of Actinomyces naeslundii phage Av-1. | Q34492001 | ||
| Bacteriophage endolysins as a novel class of antibacterial agents. | Q34505697 | ||
| High abundance of viruses found in aquatic environments. | Q34538292 | ||
| Bacteriophages: an appraisal of their role in the treatment of bacterial infections | Q34637115 | ||
| Taking aim on bacterial pathogens: from phage therapy to enzybiotics | Q34695345 | ||
| PlyC: a multimeric bacteriophage lysin | Q34708961 | ||
| Viral infections and bovine mastitis: a review | Q34740876 | ||
| Novel Method to Control Pathogenic Bacteria on Human Mucous Membranes | Q35119969 | ||
| Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections | Q35122747 | ||
| How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy | Q35903212 | ||
| Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage | Q35946160 | ||
| Bacteriophage endolysins--current state of research and applications | Q36175326 | ||
| Bacteriophage lytic enzymes: novel anti-infectives | Q36242302 | ||
| LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae | Q36313687 | ||
| Streptococcus suis: an emerging zoonotic pathogen | Q36743342 | ||
| Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin | Q36933726 | ||
| Production and application of bacteriophage and bacteriophage-encoded lysins | Q37370715 | ||
| Three Bacillus cereus bacteriophage endolysins are unrelated but reveal high homology to cell wall hydrolases from different bacilli | Q38346480 | ||
| Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains | Q39730777 | ||
| Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol | Q39740458 | ||
| A new procedure for efficient recovery of DNA, RNA, and proteins from Listeria cells by rapid lysis with a recombinant bacteriophage endolysin | Q39797252 | ||
| Characterization of a bacteriophage lysin (Ply700) from Streptococcus uberis | Q40128035 | ||
| Resistance to antimicrobial drugs--a worldwide calamity | Q40880789 | ||
| Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance | Q41816188 | ||
| PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis | Q41892311 | ||
| Use of a bacteriophage lysin, PlyC, as an enzyme disinfectant against Streptococcus equi | Q42072836 | ||
| Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. | Q42121862 | ||
| Expression of bacteriophage phiEa1h lysozyme in Escherichia coli and its activity in growth inhibition of Erwinia amylovora | Q42632691 | ||
| The Clostridium perfringens enterotoxin gene is on a transposable element in type A human food poisoning strains | Q42661388 | ||
| Use of high-affinity cell wall-binding domains of bacteriophage endolysins for immobilization and separation of bacterial cells | Q42912879 | ||
| P433 | issue | 1 | |
| P921 | main subject | bacteriophage | Q165028 |
| P304 | page(s) | 9-16 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Bioengineered bugs | Q27723000 |
| P1476 | title | Recombinant bacteriophage lysins as antibacterials | |
| P478 | volume | 1 |
| Q49941593 | Alternatives to antibiotics in poultry feed: molecular perspectives. |
| Q38165668 | Antibacterial bioagents based on principles of bacteriophage biology: an overview |
| Q27027984 | Antibiotic alternatives: the substitution of antibiotics in animal husbandry? |
| Q92697590 | Antimicrobial activity of Mycobacteriophage D29 Lysin B during Mycobacterium ulcerans infection |
| Q26781115 | Antimicrobial bacteriophage-derived proteins and therapeutic applications |
| Q38071062 | Antimicrobial enzymes: an emerging strategy to fight microbes and microbial biofilms |
| Q49631079 | Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period. |
| Q26824203 | Bacteriophage adenine methyltransferase: a life cycle regulator? Modelled using Vibrio harveyi myovirus like |
| Q38020842 | Bacteriophage based probes for pathogen detection. |
| Q34303439 | Bacteriophage endolysins as novel antimicrobials |
| Q38044739 | Bacteriophage virion-associated peptidoglycan hydrolases: potential new enzybiotics. |
| Q43245858 | Bacteriophage-Derived Peptidase CHAP(K) Eliminates and Prevents Staphylococcal Biofilms |
| Q38537430 | Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria |
| Q28082731 | Bacteriophages and phage-derived proteins--application approaches |
| Q35963673 | Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos |
| Q37607761 | Bioengineered probiotics, a strategic approach to control enteric infections |
| Q64087615 | Cell Wall Hydrolases in Bacteria: Insight on the Diversity of Cell Wall Amidases, Glycosidases and Peptidases Toward Peptidoglycan |
| Q47192883 | Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis |
| Q21245089 | Characterization and determination of holin protein of Streptococcus suis bacteriophage SMP in heterologous host |
| Q44488180 | Characterization of the staphylococcal bacteriophage lysin CHAP(K). |
| Q26744448 | Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials |
| Q37696606 | Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia |
| Q45253895 | Comparative analysis of prophages in Streptococcus mutans genomes |
| Q40899441 | Comparison between a chimeric lysin ClyH and other enzymes for extracting DNA to detect methicillin resistant Staphylococcus aureus by quantitative PCR. |
| Q59359640 | Development of Phage Lysins as Novel Therapeutics: A Historical Perspective |
| Q40948487 | Dynamics of Mycobacteriophage-Mycobacterial Host Interaction: Evidence for Secondary Mechanisms for Host Lethality |
| Q41457130 | EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis |
| Q34349552 | Engineered bacteriophage lysins as novel anti-infectives |
| Q42583742 | Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 HydH5 virion-associated peptidoglycan hydrolase: fusions, deletions, and synergy with LysH5. |
| Q64936237 | Enzymatic Hydrolysis of Pneumococcal Capsular Polysaccharide Renders the Bacterium Vulnerable to Host Defense. |
| Q41601339 | Expression of Recombinant pET22b-LysK-Cysteine/Histidine-Dependent Amidohydrolase/Peptidase Bacteriophage Therapeutic Protein in Escherichia coli BL21 (DE3). |
| Q50016493 | Formation of biofilms under phage predation: considerations concerning a biofilm increase. |
| Q34435161 | Holins in bacteria, eukaryotes, and archaea: multifunctional xenologues with potential biotechnological and biomedical applications |
| Q64276230 | In Vitro Activity of the Bacteriophage Endolysin HY-133 against Small-Colony Variants and Their Corresponding Wild Types |
| Q42055505 | In silico modeling of the staphylococcal bacteriophage-derived peptidase CHAP(K). |
| Q94452171 | In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens |
| Q36676044 | Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications |
| Q90523185 | LysPBC2, a Novel Endolysin Harboring a Bacillus cereus Spore Binding Domain |
| Q64271021 | May the Phage be With You? Prophage-Like Elements in the Genomes of Soft Rot : spp. and spp |
| Q38644054 | Microbial approaches for targeting antibiotic-resistant bacteria |
| Q39531958 | Models for the directed evolution of bacterial allelopathy: bacteriophage lysins |
| Q21134546 | Molecular characterization of podoviral bacteriophages virulent for Clostridium perfringens and their comparison with members of the Picovirinae |
| Q38219163 | New perspectives on dietary-derived treatments and food safety-antinomy in a new era. |
| Q41918953 | Next generation sequencing technologies and the changing landscape of phage genomics |
| Q24609778 | Novel highly thermostable endolysin from Thermus scotoductus MAT2119 bacteriophage Ph2119 with amino acid sequence similarity to eukaryotic peptidoglycan recognition proteins |
| Q38053102 | Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus |
| Q33726692 | Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers. |
| Q33622902 | Preclinical safety evaluation of intravenously administered SAL200 containing the recombinant phage endolysin SAL-1 as a pharmaceutical ingredient |
| Q36031358 | Prediction of peptidoglycan hydrolases- a new class of antibacterial proteins |
| Q37977367 | Rapid detection methods for Bacillus anthracis in environmental samples: a review |
| Q38363778 | Reduced Binding of the Endolysin LysTP712 to Lactococcus lactis ΔftsH Contributes to Phage Resistance. |
| Q91790583 | Rumen Virus Populations: Technological Advances Enhancing Current Understanding |
| Q51878166 | Staphylococcus bacteriophage tails with bactericidal properties: new findings. |
| Q42223992 | The novel Shewanella putrefaciens-infecting bacteriophage Spp001: genome sequence and lytic enzymes |
| Q53686608 | The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA). |
| Q21089782 | The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance |
| Q34664096 | The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice |
| Q34441804 | Thermal stability of Cpl-7 endolysin from the streptococcus pneumoniae bacteriophage Cp-7; cell wall-targeting of its CW_7 motifs |
| Q38051893 | Tools from viruses: bacteriophage successes and beyond |
| Q21133592 | Use of a bacteriophage lysin to identify a novel target for antimicrobial development |
| Q92235384 | Validation and Stabilization of a Prophage Lysin of Clostridium perfringens by Using Yeast Surface Display and Coevolutionary Models |
Search more.